These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13354740)

  • 1. Metabolic activity of 3, 3'-diiodothyronine and 3, 3'-diiodo-5-bromothyronine.
    GEMMILL CL
    Am J Physiol; 1956 Jul; 186(1):1-5. PubMed ID: 13354740
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic activity of 3,5-dibromothyronine, 3,5-diiodothyronine and 3,3'-diiodo-5-bromothyronine.
    GEMMILL CL
    Am J Physiol; 1960 Jul; 199():91-3. PubMed ID: 13827251
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of thyroxine, 3,3',5-triiodothyronine, 3,3'-diiodo-5-bromothyronine and 3,3'-diiodothyronine administered orally to rats.
    GEMMILL CL
    Am J Physiol; 1956 Nov; 187(2):323-7. PubMed ID: 13372786
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation and metabolism of 3',5'-diiodothyronine and 3,5-diiodothyronine by cultured monkey hepatocarcinoma cells.
    Sorimachi K; Cahnmann HJ
    Horm Metab Res; 1979 Mar; 11(3):233-7. PubMed ID: 109384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the metabolism of 3,3'-diiodothyronine and 3,3',5'-triiodothyronine.
    ROCHE J; MICHEL R; NUNEZ J; JACQUEMIN C
    Endocrinology; 1959 Sep; 65():402-7. PubMed ID: 14438074
    [No Abstract]   [Full Text] [Related]  

  • 6. The evaluation of DL-3'-iodothyronine and DL-3',5'-diiodothyronine as thyroxine antagonists in the rat.
    JORGENSEN EC; TSUTSUI K
    Endocrinology; 1961 Jan; 68():171-3. PubMed ID: 13790701
    [No Abstract]   [Full Text] [Related]  

  • 7. [The presence of 3, 3'-diiodothyronine and 3, 5, 3'-triiodothyroacetic acid in muscle after administration of L-3, 5, 3'-triiodothyronine to the rat].
    JOUAN P; MICHEL R; ROCHE J
    C R Seances Soc Biol Fil; 1956 Sep; 150(4):629-32. PubMed ID: 13365156
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization of mono-iodohistidine and of diiodothyronine in labelled thyroglobulin].
    ROCHE J; LISSITZKY S; MICHEL R
    C R Hebd Seances Acad Sci; 1951 May; 232(22):2047-9. PubMed ID: 14849025
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of thyroxine, 3,5-diiodothyronine and thyronine on ascorbic acid oxidation.
    GEMMILL CL
    Am J Physiol; 1951 Nov; 167(2):349-54. PubMed ID: 14894659
    [No Abstract]   [Full Text] [Related]  

  • 10. The immediate action of L-thyroxine, L-tetraiodothyroacetic acid, diiodothyronine, diiodothyroacetic acid and L-thyronine on oxygen consumption and body temperature in the hypophysectomized rat; the action of cortisone.
    VARNAI I; FARKAS M
    Acta Physiol Acad Sci Hung; 1959; 15(2):151-60. PubMed ID: 13660853
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic clearance and production rates of 3', 5'-diiodothyronine and 3,3'-diiodothyronine in man.
    Geola F; Chopra IJ; Solomon DH; Maciel RM
    J Clin Endocrinol Metab; 1979 Feb; 48(2):297-301. PubMed ID: 429483
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolism of 3:3'-diiodothyronine in man.
    STANBURY JB; MORRIS ML
    J Clin Endocrinol Metab; 1957 Nov; 17(11):1324-31. PubMed ID: 13475472
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic clearance and production rates of 3.3'-diiodothyronine, 3',5'-diiodothyronine and 3'-monoiodothyronine in hyper- and hypothyroidism.
    Faber J; Lumholtz IB; Kirkegaard C; Siersbaek-Nielsen K; Friis T
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):199-206. PubMed ID: 7067159
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of 3:5 diiodo-L-thy-ronine by L-amino acid oxidase.
    NAKANO M; DANOWSKI TS
    Endocrinology; 1960 Oct; 67():484-99. PubMed ID: 13727648
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct and rapid effects of 3,5-diiodo-L-thyronine (T2).
    Moreno M; Giacco A; Di Munno C; Goglia F
    Mol Cell Endocrinol; 2017 Dec; 458():121-126. PubMed ID: 28192176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of 3:3'-diiodo-L-thyronine].
    ROCHE J; MICHEL R; NUNEZ J; JACQUEMIN C
    C R Seances Soc Biol Fil; 1957; 151(12):2012-5. PubMed ID: 13585690
    [No Abstract]   [Full Text] [Related]  

  • 17. [Permeability of placenta to labeled 3:3'-diiodo-L-thyronine].
    NATAF B; SFEZ M; MICHEL R; ROCHE J
    C R Seances Soc Biol Fil; 1957; 151(12):2089-93. PubMed ID: 13585715
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: studies of 3',5'-diiodothyronine metabolism.
    Faber J; Kirkegaard C; Lumholtz IB; Siersbaek-Nielsen K; Friis T
    J Clin Endocrinol Metab; 1979 Apr; 48(4):611-7. PubMed ID: 429507
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 3:5-diiodo-D-thyronine on serum cholesterol.
    MCCLURE J; DE MOWBRAY RR; GILLILAND IC
    J Endocrinol; 1961 Mar; 22():87-93. PubMed ID: 13773799
    [No Abstract]   [Full Text] [Related]  

  • 20. A simple synthesis of [3,5-125I]Diiodo-L-thyroxine of high specific activity.
    Sorimachi K; Cahnmann HJ
    Endocrinology; 1977 Oct; 101(4):1276-80. PubMed ID: 908276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.